Gene · 23643
Papers4,579
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,061 to 1,080 of 4,579
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Helicobacter pylori binds human Annexins via Lipopolysaccharide to interfere with Toll-like Receptor 4 signaling. | PLoS Pathog | 2022 | 35176125 | PubTator, text mining | PubMed |
| Inhibition of miR-155 Attenuates CD14+ Monocyte-Mediated Inflammatory Response and Oxidative Stress in Psoriasis Through TLR4/MyD88/NF-κB Signaling Pathway. | Clin Cosmet Investig Dermatol | 2022 | 35173453 | PubTator, text mining | PubMed |
| E-cigarette and food flavoring diacetyl alters airway cell morphology, inflammatory and antiviral response, and susceptibility to SARS-CoV-2. | Cell Death Discov | 2022 | 35169120 | PubTator, text mining | PubMed |
| Toll-like Receptor 4, Osteoblasts and Leukemogenesis; the Lesson from Acute Myeloid Leukemia. | Molecules | 2022 | 35163998 | PubTator, text mining | PubMed |
| Involvement of Fatty Acids and Their Metabolites in the Development of Inflammation in Atherosclerosis. | Int J Mol Sci | 2022 | 35163232 | PubTator, text mining | PubMed |
| Oleacein Attenuates Lipopolysaccharide-Induced Inflammation in THP-1-Derived Macrophages by the Inhibition of TLR4/MyD88/NF-κB Pathway. | Int J Mol Sci | 2022 | 35163130 | PubTator, text mining | PubMed |
| Plasma-Derived Hemopexin as a Candidate Therapeutic Agent for Acute Vaso-Occlusion in Sickle Cell Disease: Preclinical Evidence. | J Clin Med | 2022 | 35160081 | PubTator, text mining | PubMed |
| The Rationale and Current Status of Endotoxin Adsorption in the Treatment of Septic Shock. | J Clin Med | 2022 | 35160068 | PubTator, text mining | PubMed |
| The Role of Lipopolysaccharide-Induced Cell Signalling in Chronic Inflammation. | Chronic Stress (Thousand Oaks) | 2022 | 35155966 | PubTator, text mining | PubMed |
| Cadmium and wild boar: Environmental exposure and immunological impact on macrophages. | Toxicol Rep | 2022 | 35145881 | PubTator, text mining | PubMed |
| Very low concentration of lipopolysaccharide can induce the production of various cytokines and chemokines in human primary monocytes. | BMC Res Notes | 2022 | 35144659 | PubTator, text mining | PubMed |
| A genetic screen in Drosophila reveals the role of fucosylation in host susceptibility to Candida infection. | Dis Model Mech | 2022 | 35142345 | PubTator, text mining | PubMed |
| Designing AbhiSCoVac - A single potential vaccine for all 'corona culprits': Immunoinformatics and immune simulation approaches. | J Mol Liq | 2022 | 35125571 | PubTator, text mining | PubMed |
| Lipopolysaccharide acting via toll-like receptor 4 transactivates the TGF-β receptor in vascular smooth muscle cells. | Cell Mol Life Sci | 2022 | 35122536 | PubTator, text mining | PubMed |
| Molecular insights into the interaction between human nicotinamide phosphoribosyltransferase and Toll-like receptor 4. | J Biol Chem | 2022 | 35120922 | PubTator, text mining | PubMed |
| In vivo interferon-gamma induced changes in gene expression dramatically alter neutrophil phenotype. | PLoS One | 2022 | 35113934 | PubTator, text mining | PubMed |
| Coexpression network analysis coupled with connectivity map database mining reveals novel genetic biomarkers and potential therapeutic drugs for polymyositis. | Clin Rheumatol | 2022 | 35091780 | PubTator, text mining | PubMed |
| Opioid-induced microglia reactivity modulates opioid reward, analgesia, and behavior. | Neurosci Biobehav Rev | 2022 | 35090951 | PubTator, text mining | PubMed |
| Design of a Novel Recombinant Multi-Epitope Vaccine against Triple-Negative Breast Cancer | Iran Biomed J | 2022 | 35090304 | PubTator, text mining | PubMed |
| Integrated analysis of differentially expressed genes, differentially methylated genes, and natural compounds in hepatitis C virus-induced cirrhosis. | J Int Med Res | 2022 | 35086375 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23643/papers?page=54